MKKGY Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 22:51):

Stats
Šios dienos apimtis	31 090.00
Vidutinė apimtis	107 082
Rinkos kapitalizacija	70.93B
EPS	$0.450 ( 2023-11-08 )
Kita pelno data	( $0.430 ) 2024-05-15
Last Dividend	$0.472 ( 2023-05-02 )
Next Dividend	$0 ( N/A )
P/E	23.72
ATR14	$0.0450 (0.14%)

Tūris Koreliacija

Ilgas: -0.15 (neutral)

Trumpas: -0.14 (neutral)

Signal:(51.063) Neutral

MERCK Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

MERCK Koreliacija - Valiuta/Žaliavos

0.77
( moderate )

0.69
( moderate )

0.00
( neutral )

0.65
( weak )

-0.75
( moderate negative )

MERCK Finansinės ataskaitos

Annual	2023
Pajamos:	$20.99B
Bruto pelnas:	$11.67B (55.59 %)
EPS:	$6.50

FY	2023
Pajamos:	$20.99B
Bruto pelnas:	$11.67B (55.59 %)
EPS:	$6.50

FY	2022
Pajamos:	$22.23B
Bruto pelnas:	$13.71B (61.65 %)
EPS:	$7.65

FY	2021
Pajamos:	$19.69B
Bruto pelnas:	$12.34B (62.66 %)
EPS:	$1.405

Financial Reports:

No articles found.

MERCK Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0.472 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

MERCK Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.60 - Stable (12.06%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.505	2008-03-26
Last Dividend	$0.472	2023-05-02
Next Dividend	$0	N/A
Payout Date	2023-05-11
Next Payout Date	N/A
# dividends	16	--
Total Paid Out	$4.47	--
Avg. Dividend % Per Year	0.00%	--
Score	3.37	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	5.60
Div. Directional Score	9.02	--

Next Divdend (Est)
(2025-04-18)

$0.519 Estimate 3.11 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.37

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SRCU	Ex Dividend Knight	2023-08-14	Quarterly	0.00%
HALMY	Ex Dividend Knight	2023-07-14	Semi-Annually	0.00%
AGRIP	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
NNGRY	Ex Dividend Junior	2023-09-07	Annually	0.00%
CODQL	Ex Dividend Knight	2023-08-28	Semi-Annually	0.00%
TRBK	Ex Dividend Junior	2023-08-03	Semi-Annually	0.00%
IBDRY	Ex Dividend Knight	2023-07-07	Semi-Annually	0.00%
ASMVY	Ex Dividend Junior	2023-08-18	Semi-Annually	0.00%
POAHY	Ex Dividend Knight	2023-06-30	Annually	0.00%
DURYY	Ex Dividend Junior	2023-05-15	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.135	1.500	7.31	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0575	1.200	8.08	9.70	[0 - 0.3]
returnOnEquityTTM	0.105	1.500	9.95	10.00	[0.1 - 1]
payoutRatioTTM	0.440	-1.000	5.60	-5.60	[0 - 1]
currentRatioTTM	1.425	0.800	7.88	6.30	[1 - 3]
quickRatioTTM	0.822	0.800	9.87	7.90	[0.8 - 2.5]
cashRatioTTM	0.228	1.500	9.85	10.00	[0.2 - 2]
debtRatioTTM	0.194	-1.500	6.76	-10.00	[0 - 0.6]
interestCoverageTTM	11.33	1.000	6.92	6.92	[3 - 30]
operatingCashFlowPerShareTTM	8.70	2.00	7.10	10.00	[0 - 30]
freeCashFlowPerShareTTM	4.52	2.00	7.74	10.00	[0 - 20]
debtEquityRatioTTM	0.358	-1.500	8.57	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.590	1.000	3.50	3.50	[0.2 - 0.8]
operatingProfitMarginTTM	0.182	1.000	8.36	8.36	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.396	1.000	8.91	8.91	[0.2 - 2]
assetTurnoverTTM	0.427	0.800	-0.484	-0.387	[0.5 - 2]
Total Score				12.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	4.68	1.000	9.63	0	[1 - 100]
returnOnEquityTTM	0.105	2.50	9.97	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	4.52	2.00	8.49	10.00	[0 - 30]
dividendYielPercentageTTM	1.669	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.70	2.00	7.10	10.00	[0 - 30]
payoutRatioTTM	0.440	1.500	5.60	-5.60	[0 - 1]
pegRatioTTM	-1.461	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.180	1.000	7.99	0	[0.1 - 0.5]
Total Score				5.60

MERCK

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.